• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Myriocin

Myriocin

Product ID M9634
Cas No. 35891-70-4
Purity ≥99%, TLC
Product Unit SizeCostQuantityStock
1 mg $37.30 In stock
5 mg $124.00 In stock
10 mg $206.60 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Myriocin is derived from ascomycete Isaria sinclairii. Myriocin is the parent compound of fingolimod, an immunosuppressive sphingosine-1 receptor inhibitor. Myriocin exhibits both immunosuppressive and anticancer activities. This compound inhibits serine palmitoyltransferase, preventing sphingolipid formation. In vitro, myriocin decreases expression of cylin B1, cdc2, and cdc25C and increase expression of p53 and p21, inducing G2/M phase cell cycle arrest and inhibiting growth of melanoma cells. In animal models, myriocin decreases levels of CD4+ lymphocytes and alters the total lymphocyte populations.

Product Info

Cas No.

35891-70-4

Purity

≥99%, TLC

Formula

C21H39NO6

Formula Wt.

401.54

IUPAC Name

(E,2S,3R,4R)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid

Melting Point

175-180C

Solubility

DMSO (25 mg/ml; heat briefly in boiling water bath); soluble in dilute base (50 mM NaOH) to ~5 mg/ml and methanol: 2 mg/mL

Appearance

White to off white powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

M9634 MSDS PDF

Info Sheet

M9634 Info Sheet PDF

References

Wadsworth JM, Clarke DJ, McMahon SA, et al. The chemical basis of serine palmitoyltransferase inhibition by myriocin. J Am Chem Soc. 2013 Sep 25;135(38):14276-85. PMID: 23957439.

Lee YS, Choi KM, Choi MH, et al. Serine palmitoyltransferase inhibitor myriocin induces growth inhibition of B16F10 melanoma cells through G(2) /M phase arrest. Cell Prolif. 2011 Aug;44(4):320-9. PMID: 21645154.

Chiba K, Matsuyuki H, Maeda Y, et al. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. Cell Mol Immunol. 2006 Feb;3(1):11-9. PMID: 16549044.

Johnson VJ, He Q, Osuchowski MF, et al. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations. Toxicology. 2004 Sep 1;201(1-3):67-75. PMID: 15297021.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M0368

    Marbofloxacin

    Fluoroquinolone; bacterial DNA gyrase inhibitor.
    ≥98%
  • S8006

    Substance P (1-4)

    Endogenous tachykinin peptide, involved in inflamm...
    ≥95%
  • T6933

    Trichostatin A

    HDAC inhibitor, mammalian RNA splicing modulator.
    ≥98%
  • E5201

    Enalapril Maleate

    ACE inhibitor.
    ≥98%
  • A0820

    N-Acetyl-S-(N′-benzylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate, BITC derivative, antioxida...
    ≥98%
  • T2404

    TG101348

    JAK2 inhibitor.
    ≥98%
  • A0802

    Acarbose

    α-glucosidase inhibitor.
    ≥98%
  • N1721

    Nefiracetam

    Pyrrolidone; NMDA and mGluR5 agonist, N-type and L...
    ≥98%
  • G0668

    GBR 12935 Dihydrochloride

    DAT inhibitor.
    ≥98%
  • R3249

    Rimantadine Hydrochloride

    Viral M2 proton channel blocker.
    ≥98%
  • E7731

    17-α-Ethynylestradiol

    Synthetic steroid hormone; ER agonist.
    ≥98%
  • N0163

    2-(1,8-Naphthyridin-2-yl)phenol

    Naphthalene; indirect STAT1 agonist.
    ≥98%
  • A9601

    AZD-5363

    AKT inhibitor, potential ROCK, p70S6K, PKA, MKK1, ...
    ≥99%, ≥99%ee
  • P0256

    Pantoprazole Sodium Sesquihydrate

    H+/K+ ATPase and ROCK-2 inhibitor.
    ≥98%
  • P6002

    PP-121

    p110α PI3K, DNA-PK, mTOR, Abl, Hck, Src, VEGFR2, ...
    ≥98%
  • J766160

    JTE907

    Selective Cannabinoid receptor 2(CB2) inverse agon...
    ≥98%
  • A9708

    AZD-1208

    Pim-1 inhibitor.
    ≥98%
  • B6808

    [Des-Pro2]-Bradykinin

    Natriuretic, vasodilatory peptide, bradykinin anal...
    ≥95%
  • W0270

    (±)-Warfarin Sodium Clathrate

    Coumarin; VKORC1 inhibitor.
    ≥98%
  • I7455

    R-1-Isothiocyanato-7-(methylsulfinyl)-heptane

    ITC, antioxidant.
    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only